CA2402562A1 - A process for the production of human interferon alpha from genetically engineered yeast - Google Patents

A process for the production of human interferon alpha from genetically engineered yeast Download PDF

Info

Publication number
CA2402562A1
CA2402562A1 CA002402562A CA2402562A CA2402562A1 CA 2402562 A1 CA2402562 A1 CA 2402562A1 CA 002402562 A CA002402562 A CA 002402562A CA 2402562 A CA2402562 A CA 2402562A CA 2402562 A1 CA2402562 A1 CA 2402562A1
Authority
CA
Canada
Prior art keywords
interferon alpha
pichia pastoris
extract
yielding
human interferon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002402562A
Other languages
English (en)
French (fr)
Inventor
Kondra Venkat Sudhir
Chaganti Revathi Jogulamma
Akundi Venkata Sriram
Kolli Satya Narayana Prasad
Kondiboyina Venkata Ramana
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shantha Biotechnics Pvt Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2402562A1 publication Critical patent/CA2402562A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
CA002402562A 2000-03-16 2000-03-16 A process for the production of human interferon alpha from genetically engineered yeast Abandoned CA2402562A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2000/000339 WO2001068827A1 (en) 2000-03-16 2000-03-16 A process for the production of human interferon alpha from genetically engineered yeast

Publications (1)

Publication Number Publication Date
CA2402562A1 true CA2402562A1 (en) 2001-09-20

Family

ID=11003897

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002402562A Abandoned CA2402562A1 (en) 2000-03-16 2000-03-16 A process for the production of human interferon alpha from genetically engineered yeast

Country Status (6)

Country Link
EP (1) EP1272624A4 (zh)
JP (1) JP2003526365A (zh)
CN (1) CN1452658A (zh)
AU (1) AU2000231863A1 (zh)
CA (1) CA2402562A1 (zh)
WO (1) WO2001068827A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004039996A1 (en) * 2002-11-01 2004-05-13 Cadila Healthcare Limited Mthod for producing recombinant human interferon alpha 2b polypeptide in pichia pastoris
US8906676B2 (en) 2004-02-02 2014-12-09 Ambrx, Inc. Modified human four helical bundle polypeptides and their uses
AU2008201682B2 (en) * 2004-02-02 2011-02-24 Ambrx, Inc. Modified human interferon polypeptides and their uses
CU24158B1 (es) * 2012-09-18 2016-03-30 Ct De Ingeniería Genética Y Biotecnología Método de obtención de 1-kestosa

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL90021A0 (en) * 1988-04-25 1989-12-15 Phillips Petroleum Co Process for the production of interferon
JPH06209763A (ja) * 1993-01-13 1994-08-02 Green Cross Corp:The 変異株

Also Published As

Publication number Publication date
EP1272624A4 (en) 2004-06-16
EP1272624A1 (en) 2003-01-08
JP2003526365A (ja) 2003-09-09
WO2001068827A1 (en) 2001-09-20
AU2000231863A1 (en) 2001-09-24
CN1452658A (zh) 2003-10-29

Similar Documents

Publication Publication Date Title
EP0060057B1 (en) Expression of polypeptides in yeast
CA1339707C (en) Formulations for recombinant beta-interferon
AU617656B2 (en) Purification of recombinant beta-interferon incorporating rp-hplc
JPH07163368A (ja) 組換えｄｎａとその組換えｄｎａを含む形質転換体
EP0796269A1 (en) Filtration
HU204095B (en) Process for producing yeast vectors
US4935352A (en) Expression vector for animal cell line and use thereof
Swaminathan et al. Affinity purification of recombinant interferon-α on a mimetic ligand adsorbent
CA2402562A1 (en) A process for the production of human interferon alpha from genetically engineered yeast
Khan et al. Large-scale production of recombinant proteins: human leukocyte interferon
Perez et al. Production and characterization of human gamma interferon from Escherichia coli
KR20200120908A (ko) 목적 단백질을 생산하기 위한 숙주 세포
EP2532734B1 (en) Process for the production of interferon alpha 5
EP0126230A1 (en) Novel DNA and use thereof
CA2148935A1 (en) Purification of fusion proteins comprising gm-csf and il-3
US5981227A (en) Process for the production of proteins
Jeong et al. Supply of the argU gene product allows high-level expression of recombinant human interferon-a2a in Escherichia coli
EP0227833B1 (en) Process for preparing hetero-protein
US20220119494A1 (en) Recombinant vector, host cell and process for production of human serum albumin
Katla et al. Yeasts as Microbial Factories for Production of Recombinant Human Interferon Alpha 2b of Therapeutic Importance
AU682274C (en) Filtration
MCGREGOR et al. METHODS OF PREPARATION
GB2112395A (en) Recombinant cloning vector
HU204087B (en) Process for producing humqn alpha or beta interferon
Ramel et al. Methods of preparation

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued